Characteristics of patients with NHL or CLL [31].
收藏NIAID Data Ecosystem2026-03-13 收录
数据链接：
官方服务：
资源简介：
Characteristics of patients with NHL or CLL [31].
应用场景：
创建时间：
2022-03-18
相关数据集
Phase 1 study of inotuzumab ozogamicin combined with R-GDP for the treatment of patients with relapsed/refractory CD22+ B-cell non-Hodgkin lymphoma
Objective : To evaluate safety, tolerability, and preliminary activity of inotuzumab ozogamicin (InO) plus rituximab, gemcitabine, dexamethasone, and cisplatin (R-GDP) in patients with relapsed/
DataCite Commons2020-09-02 更新70
Supplementary methods data.
Characteristics of the series of 197 CLL patients with 11q deletion (Table A). Univariate analysis of time to first therapy in 11q- CLL patients with respect to the number of losses detected by FISH:
NIAID Data Ecosystem20
Cost-Effectiveness of BTK Inhibitors versus Bendamustine and Rituximab in Chronic Lymphocytic Leukaemia Patients - supplementary material
Table S1 AIC and BIC parameters
DataCite Commons2024-05-15 更新10
Supplementary Material for: Treatment-free remission in real-world chronic myeloid leukemia patients: Insights from German hematology practices
Introduction Treatment-free remission (TFR) is increasingly considered as treatment goal for patients with chronic myeloid leukemia (CML), but information on the disposition and outcome of TFR in clin
DataCite Commons2022-09-08 更新50
Results of adjusted a space-time cluster analyses performed in SpaceStat, based on 15 nearest neighbours, 999 permutations, and by three different time scales.
aAdjusted for previous history of autoimmune disease, HIV/AIDS or organ transplantation. bThe total number of statistically significant cases with a Qik p-value of 0.001, which indicates the number of
NIAID Data Ecosystem10
